H-NMR metabolic markers of malignancy correlate with spontaneous metastases in a murine mammary tumor model

International Journal of Oncology

Volumn 27, Issue 1, 2005, Pages 257-263

  Whitehead, Tracy L ^a   Monzavi Karbassi, Behjatolah ^a   Jousheghany, Fariba ^a   Artaud, Cecile ^a   Elbein, Alan ^b   Kieber Emmons, Thomas ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Carbohydrate antigens; Mammary carcinoma; Solution state NMR; Warburg effect

Indexed keywords

5 ACETYLNEURAMINYL (2 3) GALACTOSYL (1 4) (FUCOPYRANOSYL (1 3)) N ACETYLGLUCOSAMINE; 5-ACETYLNEURAMINYL-(2-3)-GALACTOSYL-(1-4)-(FUCOPYRANOSYL-(1-3))-N-ACETYLGLUCOSAMINE; BIOLOGICAL MARKER; CARBENE; DRUG DERIVATIVE; HYDROCARBON; METHANE; OLIGOSACCHARIDE; PHOSPHORYLCHOLINE; TUMOR ANTIGEN; TUMOR MARKER;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL ADHESION; CELL PROLIFERATION; CELL SEPARATION; CHEMISTRY; EXPERIMENTAL NEOPLASM; FLOW CYTOMETRY; GLYCOLYSIS; HUMAN; METABOLISM; METASTASIS; METHODOLOGY; MOUSE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PHENOTYPE; PROGNOSIS; TIME;

ANIMALS; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; CELL ADHESION; CELL PROLIFERATION; CELL SEPARATION; FLOW CYTOMETRY; GLYCOLYSIS; HUMANS; HYDROCARBONS; MAGNETIC RESONANCE SPECTROSCOPY; MAMMARY NEOPLASMS, ANIMAL; METHANE; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; OLIGOSACCHARIDES; PHENOTYPE; PHOSPHORYLCHOLINE; PROGNOSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 24644513819     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Warburg O: On the origin of cancer cells. Science 123: 309-314, 1956.
2. Gatenby RA and Gillies RJ: Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899, 2004.
3. Walenta S and Mueller-Klieser WF: Lactate: mirror and motor of tumor malignancy. Semin Radiât Oncol 14: 267-274, 2004.
4. Lu H, Forbes RA and Verma A: Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277: 23111-23115, 2002.
5. Ackerstaff E, Glunde K and Bhujwalla ZM: Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem 90: 525-533, 2003.
6. Kannagi R: Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression - The Warburg effect revisited. Glycoconjugate J 20: 353-364, 2004.
7. Koike T, Kimura N, Miyazaki K, Yabuta T, Kumamoto K, Takenoshita S, Chen J, Kobayashi M, Hosokawa M, Taniguchi A, Kojima T, Ishida N, Kawakita M, Yamamoto H, Takematsu H, Suzuki A, Kozutsumi Y and Kannagi R: Hypoxia induces adhesion molecules on cancer cells: a missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proc Natl Acad Sei USA 101: 8132-8137, 2004.
8. Liu F, Zhang Y, Zhang XY and Chen HL: Transfection of the nm23-Hl gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, alpha 1, 3 fucosyltransferase VII, and metastatic potential. J Cancer Res Clin Oncol 128: 189-196,2003.
9. Alpaugh ML, Tomlinson JS, Ye Y and Barsky SH: Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma. Am J Pathol 161:619-628,2002.
10. Alpaugh ML and Barsky SH: Reversible model of spheroid formation allows for high efficiency of gene delivery ex vivo and accurate gene assessment in vivo. Hum Gene Ther 13: 1245-1258,2002.
11. Monzavi-Karbassi B, Cunto-Amesty G, Luo P, Shamloo S, Blaszcyk-Thurin M and Kieber-Emmons T: Immunization with a carbohydrate mimicking peptide augments tumor-specfic cellular responses. Int Immunol 13: 1361-1371,2001.
12. Pulaski BA and Ostrand-Rosenberg S: Mouse 4T1 breast tumor model. In: Current Protocols in Immunology. Coligan JE, Kruisbeek AM, Margulies DH, Shevach E and Strober W (eds.). John Wiley & Sons, Inc., 3: 20.2.1-20.2.16, 2000.
13. Aslakson CJ and Miller FR: Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52: 1399-1405, 1992.
14. Lean CL, Mackinnon WB, Delikatny J, Whitehead RH and Mountford CE: Cell-surface fucosylation and magnetic resonance spectroscopy characterization of human malignant colorectal cells. Biochemistry 31: 11095-11105, 1992.
15. Piotto M, Saudek V and Sklenar V: Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J Biomol NMR 2: 661-665, 1992.
16. Ogg RJ, Kingley PB and Taylor JS: WET, a Tr and Br insensitive water-suppression method for in vivo localized 'H-NMR spectroscopy. J Magn Reson B 104: 1-10, 1994.
17. Hanai, N, Shitara K and Yoshida H: Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung. Cancer Res 46: 4438-4443, 1986.
18. Fukushima K, Hirota M, Terasaki PI, Wakisaka A, Togashi H, Chia D, Suyama N, Fukushi Y, Nudelman E and Hakomori S: Characterization of sialosylated Lewis x as a new tumor-associated antigen. Cancer Res 44: 5279-5285, 1984.
19. Fukushi Y, Nudelman E, Levery SB, Hakomori S and Rauvala H: Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6). J Biol Chem 259: 10511-10517, 1984.
20. Haglund C, Lindgren J, Roberts PJ and Nordling S: Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions: a comparison with CA 19-9. Int J Cancer 38: 841-846, 1986.
21. Mackinnon WB, Russell P, May GL and Mountford CE: Characterization of human epithelial tumors (ex vivo) by proton magnetic resonance spectroscopy. Int J Gynecol Cancer 5: 211-221,1995.
22. Mackinnon WB, Delbridge L, Russell P, Lean CL, May GL, Doran S, Dowd S and Mountford CE: Two-dimensional proton magnetic resonance spectroscopy for tissue characterization of thyroid neoplasms. World J Surg 20: 841-847, 1996.
23. Gribbestad I, Sitter B, Lundgren S, Krane J and Axelson D: Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res 19: 1737-1746, 1999.
24. Sitter B, Sonnewald U, Spraul M, Fjösne HE and Gribbestad IS: High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed 15: 327-337, 2002.
25. Aboagye EO and Bhujwalla ZM: Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 59: 80-84, 1999.
26. Fossel ET, Carr JM and McDonagh J: Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. N Engl J Med 315: 1369-1376, 1986.
27. Walenta S, Wetterling M, Lehrke M, Schwickert G, Sundfor K, Rofstad EK and Mueller-Klieser W: High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 60: 916-921, 2000.